Replies to post #511194 on NorthWest Biotherapeutics Inc (NWBO)

[Roman516]

Great information and to the point. Yes, indeed DCVax-L will become a preferred SOC, IMPO.

[dlongava]

Correct, thanks for clarification SL2020. HyGro should read the link you provided at clinicaltrials.gov for a better understanding.

[biosectinvestor]

Well said.

[HyGro]

You can't be a Standard of Care if you are NOT commercially available and in common use by medical professionals. DCVax-L is certainly not either of those.

ATL is used as the comparator. That's it.